Based on the analysis of Globus Medical's profitability, liquidity, and operating efficiency, Globus Medical may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Globus Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 320.6 M, whereas Current Deferred Revenue is forecasted to decline to about 9.6 M. Key indicators impacting Globus Medical's financial strength include:
The financial analysis of Globus Medical is a critical element in measuring its lifeblood. Investors should not minimize Globus Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
117.3 Million
Globus
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Change Receivables
Total Cashflows From Investing Activities
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Investments
Change To Operating Activities
Issuance Of Capital Stock
Common Stock Shares Outstanding
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Common Stock
Property Plant Equipment
Good Will
Intangible Assets
Net Tangible Assets
Retained Earnings Total Equity
Short Term Investments
Capital Surpluse
Deferred Long Term Liab
Non Current Liabilities Other
Long Term Investments
Deferred Long Term Asset Charges
Net Invested Capital
Net Working Capital
Capital Stock
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Globus Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Globus Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Globus Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.
Globus Medical Stock Summary
Globus Medical competes with Orthofix Medical, CONMED, Alphatec Holdings, LivaNova PLC, and Integer Holdings. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.
Comparative valuation techniques use various fundamental indicators to help in determining Globus Medical's current stock value. Our valuation model uses many indicators to compare Globus Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Globus Medical competition to find correlations between indicators driving Globus Medical's intrinsic value. More Info.
Globus Medical is rated below average in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about 4.46 of Return On Asset per Return On Equity. At present, Globus Medical's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Globus Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Globus Medical Systematic Risk
Globus Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Globus Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Globus Medical correlated with the market. If Beta is less than 0 Globus Medical generally moves in the opposite direction as compared to the market. If Globus Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Globus Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Globus Medical is generally in the same direction as the market. If Beta > 1 Globus Medical moves generally in the same direction as, but more than the movement of the benchmark.
Globus Medical Thematic Clasifications
Globus Medical is part of several thematic ideas from Obamacare Repeal to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Globus Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Globus Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Globus Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(1.22)
At present, Globus Medical's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Globus Medical October 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Globus Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Globus Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Globus Medical based on widely used predictive technical indicators. In general, we focus on analyzing Globus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Globus Medical's daily price indicators and compare them against related drivers.
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance